Lawsuit Update
$2.2 Billion Zantac Cancer Lawsuit & Settlement Update -- May 2026
GSK's $2.2B settlement (~93% of state-court cases / ~80,000 plaintiffs) is disbursing through plaintiff firms. Boehringer Ingelheim, Pfizer, and Sanofi state-court cases continue. Intake firms are still reviewing brand-name OTC Zantac (Zantac 75 / Zantac 150) cases for bladder, esophageal, liver, pancreatic, or stomach cancer.